BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31237543)

  • 1. Pulmonary Function Testing and Outcomes after Left Ventricular Assist Device Implantation.
    Raheja S; Nemeh H; Williams C; Tita C; Selektor Y; Chamogeorgiakis T; Lanfear D
    Heart Surg Forum; 2019 May; 22(3):E202-E206. PubMed ID: 31237543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary function assessment post-left ventricular assist device implantation.
    Sajgalik P; Kim CH; Stulak JM; Kushwaha SS; Maltais S; Joyce DL; Joyce LD; Johnson BD; Schirger JA
    ESC Heart Fail; 2019 Feb; 6(1):53-61. PubMed ID: 30311748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of Residual Mitral Regurgitation After Continuous Flow Left Ventricular Assist Device Implantation.
    Kassis H; Cherukuri K; Agarwal R; Kanwar M; Elapavaluru S; Sokos GG; Moraca RJ; Bailey SH; Murali S; Benza RL; Raina A
    JACC Heart Fail; 2017 Feb; 5(2):81-88. PubMed ID: 28017353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in Spirometry After Left Ventricular Assist Device Implantation.
    Mohamedali B; Bhat G; Yost G; Tatooles A
    Artif Organs; 2015 Dec; 39(12):1046-50. PubMed ID: 25994850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The predictive value of preimplant pulmonary function testing in LVAD patients.
    Hess NR; Seese LM; Hickey GW; Keebler ME; Wang Y; Thoma F; Kilic A
    J Card Surg; 2021 Jan; 36(1):105-110. PubMed ID: 33124124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of global and disease-specific health status with outcomes following continuous-flow left ventricular assist device implantation.
    Flint KM; Spertus JA; Tang F; Jones P; Fendler TJ; Allen LA
    BMC Cardiovasc Disord; 2017 Mar; 17(1):78. PubMed ID: 28288574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Outcomes of Patients Treated With Pulmonary Vasodilators Early and in High Dose After Left Ventricular Assist Device Implantation.
    Critoph C; Green G; Hayes H; Baumwol J; Lam K; Larbalestier R; Chih S
    Artif Organs; 2016 Jan; 40(1):106-14. PubMed ID: 25994765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients.
    Rogers JG; Aaronson KD; Boyle AJ; Russell SD; Milano CA; Pagani FD; Edwards BS; Park S; John R; Conte JV; Farrar DJ; Slaughter MS;
    J Am Coll Cardiol; 2010 Apr; 55(17):1826-34. PubMed ID: 20413033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fine-tuning management of the Heart Assist 5 left ventricular assist device with two- and three-dimensional echocardiography.
    Demirozu ZT; Arat N; Kucukaksu DS
    Cardiovasc J Afr; 2016; 27(4):208-212. PubMed ID: 27841907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Right heart failure and "failure to thrive" after left ventricular assist device: clinical predictors and outcomes.
    Baumwol J; Macdonald PS; Keogh AM; Kotlyar E; Spratt P; Jansz P; Hayward CS
    J Heart Lung Transplant; 2011 Aug; 30(8):888-95. PubMed ID: 21530314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limiting factors of peak and submaximal exercise capacity in LVAD patients.
    Fresiello L; Jacobs S; Timmermans P; Buys R; Hornikx M; Goetschalckx K; Droogne W; Meyns B
    PLoS One; 2020; 15(7):e0235684. PubMed ID: 32645710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac rehabilitation improves functional capacity and patient-reported health status in patients with continuous-flow left ventricular assist devices: the Rehab-VAD randomized controlled trial.
    Kerrigan DJ; Williams CT; Ehrman JK; Saval MA; Bronsteen K; Schairer JR; Swaffer M; Brawner CA; Lanfear DE; Selektor Y; Velez M; Tita C; Keteyian SJ
    JACC Heart Fail; 2014 Dec; 2(6):653-9. PubMed ID: 25447348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of functional capacity in patients with end-stage heart failure following implantation of a left ventricular assist device versus heart transplantation: results of the experience with left ventricular assist device with exercise trial.
    Jaski BE; Lingle RJ; Kim J; Branch KR; Goldsmith R; Johnson MR; Lahpor JR; Icenogle TB; Piña I; Adamson R; Favrot LK; Dembitsky WP
    J Heart Lung Transplant; 1999 Nov; 18(11):1031-40. PubMed ID: 10598726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of concomitant cardiac procedures performed during implantation of long-term left ventricular assist devices.
    Morgan JA; Tsiouris A; Nemeh HW; Hodari A; Karam J; Brewer RJ; Paone G
    J Heart Lung Transplant; 2013 Dec; 32(12):1255-61. PubMed ID: 24135274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient-Reported Health-Related Quality of Life Is a Predictor of Outcomes in Ambulatory Heart Failure Patients Treated With Left Ventricular Assist Device Compared With Medical Management: Results From the ROADMAP Study (Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management).
    Stehlik J; Estep JD; Selzman CH; Rogers JG; Spertus JA; Shah KB; Chuang J; Farrar DJ; Starling RC;
    Circ Heart Fail; 2017 Jun; 10(6):. PubMed ID: 28611126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in cardiopulmonary exercise testing parameters following continuous flow left ventricular assist device implantation and heart transplantation.
    Dunlay SM; Allison TG; Pereira NL
    J Card Fail; 2014 Aug; 20(8):548-54. PubMed ID: 24893345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients: The ROADMAP Study 2-Year Results.
    Starling RC; Estep JD; Horstmanshof DA; Milano CA; Stehlik J; Shah KB; Bruckner BA; Lee S; Long JW; Selzman CH; Kasirajan V; Haas DC; Boyle AJ; Chuang J; Farrar DJ; Rogers JG;
    JACC Heart Fail; 2017 Jul; 5(7):518-527. PubMed ID: 28396040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of age on outcomes following continuous-flow left ventricular assist device implantation.
    Lushaj EB; Badami A; Osaki S; Murray M; Leverson G; Lozonschi L; Akhter S; Kohmoto T
    Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):743-8. PubMed ID: 25770085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of tricuspid repair at the time of left ventricular assist device implantation and survival.
    Brewer RJ; Cabrera R; El-Atrache M; Zafar A; Hrobowski TN; Nemeh HM; Selektor Y; Paone G; Williams CT; Velez M; Tita C; Morgan JA; Lanfear DE
    Int J Artif Organs; 2014 Nov; 37(11):834-8. PubMed ID: 25450319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.